Maintenance treatment for new, mild asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial is testing whether starting treatment with a combination anti-inflammatory and reliever inhaler can help people with new, mild asthma control their symptoms better. It compares different treatment strategies to find the best approach for early asthma care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old and newly diagnosed with mild asthma.
- You have had a positive breathing test showing reversible airway narrowing.
- You do not have other serious lung or heart diseases, and you are not pregnant or breastfeeding.
- You have not used certain asthma medications (like montelukast or steroid pills) recently.
- You have not smoked in the last 6 months and do not have a heavy smoking history.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how stepping up asthma treatment affects asthma control in people with mild to moderate asthma. You may be asked to use study inhalers correctly and track symptoms and lung tests to see if control improves.
This trial tests if adding immune-modulating tablets (Staphylococcus and Neisseria) to standard asthma medication (budesonide formoterol) helps control asthma better. It is for people whose asthma is not well controlled despite current treatment.
This trial tests a new inhaled medicine called PA9159 for adults with moderate asthma. It compares the medicine to a placebo to see if it safely improves breathing and controls asthma symptoms.
This trial tests an inhaled asthma medication, PA9159, in adults with stable or mild-to-moderate asthma. It aims to see if the drug improves lung function and is safe. You may qualify if you have asthma with some airflow limitation and have not had recent severe flare-ups.
This study tests a new combination inhaler for people with asthma. It may help control symptoms and improve breathing. Participants will either get the study inhaler or a standard treatment, and their asthma will be monitored closely.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
Hear when a new Bronchial Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.